CMMBChemomab Therapeutics Ltd. American Depositary Share

ADRCNasdaq (XNAS)·USD

Identity

Security key: 13534
Ticker: CMMB
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-03-17
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: CMMB

Detail

Enriched 2026-08-14 20:47

Market cap: $14,069,107.2
Shares outstanding (class): 7,200,378
Shares outstanding (weighted): 7,327,660
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 12
Location: TEL AVIV, L3
Homepage: https://www.chemomab.com
Description: Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Market cap and share counts drift.

Funds holding this security

as of 2026-03-31

No reported positions at this date.

Positions are reached through OpenFIGI-resolved ISINs. A security with no resolved ISIN cannot be found this way even if funds do hold it.

Funds holding this security

Identifiers

master.security_identifier

TICKERCMMB
FIGI_COMPOSITEBBG00N0PMGK1
FIGI_SHARE_CLASSBBG00N0PMH92
CIK0001534248

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Chemomab Therapeutics is a biopharmaceutical company developing therapies, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.